Theracryf Plc
Status: Publicly traded
Direct answer
Theracryf Plc is publicly traded on LSE under the ticker TCF.L.
Theracryf Plc operates as a clinical-stage biotechnology firm, dedicated to advancing treatments for oncological diseases and various brain disorders affecting behavior. Its primary therapeutic asset, SFX-01, is currently progressing through Phase II clinical trials for metastatic breast cancer. Additionally, SFX-01 is in Phase I trials for neurodevelopmental conditions and glioblastoma, and is undergoing...
Can you invest in Theracryf Plc?
Yes. Theracryf Plc is publicly traded on LSE under the ticker TCF.L.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Theracryf Plc
Detailed equity research is provided by MarketSnap.